|
Canada-ON-PARIS Azienda Directories
|
Azienda News:
- Prolia® (denosumab) for Postmenopausal Osteoporosis
Prolia ® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture
- Results for Postmenopausal Osteoporosis | Prolia® (denosumab)
Find a 3-year clinical study on Prolia® and learn how it works to treat women with postmenopausal osteoporosis See full prescribing safety info Approved Uses
- How Does Prolia® (denosumab) Work?
Learn about how Prolia® works to stop bone-removing cells before they can reach and damage the bone in people with osteoporosis See full prescribing safety info Approved Uses
- How to Start Prolia® (denosumab)
Find Prolia® injection administration information, dosing schedule, and what to expect when starting treatment See full prescribing safety info Approved Uses
- Patient Resources | Prolia® (denosumab)
Prolia ® is a prescription medicine used to treat osteoporosis in men and women who will be taking corticosteroid medicines (such as prednisone) for at least six months and are at high risk for fracture
- Treating Postmenopausal Osteoporosis | Prolia® (denosumab)
Learn about Prolia® as a treatment option for postmenopausal osteoporosis and find ways to talk to your doctor to get started on your treatment journey See full prescribing safety info Approved Uses
- Prolia® (denosumab) Cost and Copay Information
Find the cost of Prolia® depending on your insurance coverage, as well as additional patient support through the Bone Matters® program See full prescribing safety info Approved Uses
- Other Conditions | Prolia® (denosumab)
The most common side effects of Prolia ® in patients receiving certain treatments for prostate or breast cancer are joint pain, back pain, pain in your arms and legs, and muscle pain Additionally, in Prolia ®-treated men with nonmetastatic prostate cancer receiving ADT, a greater incidence of cataracts was observed
- Real-World Study Results | Prolia® (denosumab)
In the Prolia ® 3-Year fracture trial, women taking Prolia ® for 3 years significantly reduced new spine fracture risk What is a REAL-WORLD STUDY? After FDA approval, patients begin using the medication as part of their routine medical care
- Real Patient Stories | Prolia® (denosumab)
Watch real stories of patients living with postmenopausal osteoporosis to learn how Prolia® worked for them See full prescribing safety info
|
|